Integral Health Asset Management, LLC
An institutional investment manager in New York, NY. Its Form 13F for the quarter ended Jun 30, 2026, filed Aug 14, 2026. SEC CIK 1773206.
- Reported value$2.53bn
- Positions92
Holdings: 92 positions
The filing on sec.govAs filed, largest first. Reported value is what the manager stated for each position at the quarter end, in US dollars; it is filing data, not a price. Weight is the position's share of the total reported value. Changes compare with the 13F for the quarter ended 2026-03-31.
| Issuer | Class | CUSIP | Reported value$m | Weight | Shares | Put or call | Change on the quarter before |
|---|---|---|---|---|---|---|---|
| Revolution Medicines IncRVMD | COM | 76155X100 | 281 | 11.1% | 1,500,000 | Unchanged | |
| Insmed IncINSM | COM PAR $.01 | 457669307 | 171 | 6.7% | 1,600,000 | Added+100,000 | |
| Cytokinetics IncCYTK | COM NEW | 23282W605 | 136 | 5.4% | 1,600,000 | Unchanged | |
| CVS Health CorpCVS | COM | 126650100 | 114 | 4.5% | 1,100,000 | Added+950,000 | |
| Edgewise Therapeutics IncEWTX | COM | 28036F105 | 81.3 | 3.2% | 2,000,000 | Added+400,000 | |
| Vera Therapeutics IncVERA | CL A | 92337R101 | 75.1 | 3.0% | 1,750,000 | Added+150,000 | |
| Axsome Therapeutics Inc.AXSM | COM | 05464T104 | 73.4 | 2.9% | 300,000 | Added+265,000 | |
| Cardinal Health IncCAH | COM | 14149Y108 | 71.3 | 2.8% | 300,000 | Added+30,000 | |
| Roivant Sciences Ltd | SHS | G76279101 | 70.8 | 2.8% | 2,000,000 | Unchanged | |
| Rhythm Pharmaceuticals IncRYTM | COM | 76243J105 | 61.1 | 2.4% | 550,000 | Reduced−50,000 | |
| Edwards Lifesciences CorpEW | COM | 28176E108 | 56.5 | 2.2% | 625,000 | Added+455,000 | |
| Revolution Medicines IncRVMD | COM | 76155X100 | 56.2 | 2.2% | 300,000 | Put | Reduced−450,000 |
| Alignment Healthcare IncALHC | COM | 01625V104 | 47.6 | 1.9% | 2,000,000 | Reduced−575,000 | |
| Merck & Co IncMRK | COM | 58933Y105 | 45.0 | 1.8% | 350,000 | Reduced−75,000 | |
| Quest Diagnostics IncDGX | COM | 74834L100 | 42.4 | 1.7% | 200,000 | Added+140,000 | |
| Uniqure NV | SHS | N90064101 | 41.5 | 1.6% | 900,000 | Unchanged | |
| Scholar Rock HLDG CorpSRRK | COM | 80706P103 | 41.3 | 1.6% | 750,000 | Added+250,000 | |
| Boston Scientific CorpBSX | COM | 101137107 | 38.4 | 1.5% | 900,000 | Added+350,000 | |
| Brightspring Health SVCS IncBTSG | COM | 10950A106 | 38.4 | 1.5% | 550,000 | Reduced−700,000 | |
| Abbott LaboratoriesABT | COM | 002824100 | 36.3 | 1.4% | 400,000 | New+400,000 | |
| Unitedhealth Group IncUNH | COM | 91324P102 | 35.3 | 1.4% | 85,000 | New+85,000 | |
| Lifestance Health Group IncLFST | COM | 53228F101 | 32.1 | 1.3% | 3,000,000 | Reduced−1,300,000 | |
| Novartis AGNVS | SPONSORED ADR | 66987V109 | 31.3 | 1.2% | 200,000 | Reduced−50,000 | |
| Tango Therapeutics IncTNGX | COM | 87583X109 | 31.3 | 1.2% | 1,000,000 | Added+550,000 | |
| Tenet Healthcare CorpTHC | COM NEW | 88033G407 | 30.9 | 1.2% | 165,000 | New+165,000 | |
| Spyre Therapeutics IncSYRE | COM NEW | 00773J202 | 28.9 | 1.1% | 325,000 | New+325,000 | |
| Novo-Nordisk a SNVO | ADR | 670100205 | 28.8 | 1.1% | 600,000 | New+600,000 | |
| Definium Therapeutics IncDFTX | COM SHS | 24477V105 | 25.9 | 1.0% | 550,000 | Added+150,000 | |
| Neurocrine Biosciences IncNBIX | COM | 64125C109 | 25.3 | 1.0% | 150,000 | Unchanged | |
| Regeneron PharmaceuticalsREGN | COM | 75886F107 | 24.9 | 1.0% | 40,000 | Reduced−45,000 | |
| Ionis Pharmaceuticals IncIONS | COM | 462222100 | 23.8 | 0.9% | 300,000 | Call | New+300,000 |
| Biogen IncBIIB | COM | 09062X103 | 21.6 | 0.9% | 100,000 | Added+40,000 | |
| Travere Therapeutics IncTVTX | COM | 89422G107 | 21.3 | 0.8% | 375,000 | New+375,000 | |
| Lantheus Holdings IncLNTH | COM | 516544103 | 21.1 | 0.8% | 190,000 | Added+65,000 | |
| Glaukos CorpGKOS | COM | 377322102 | 21.0 | 0.8% | 150,000 | Reduced−25,000 | |
| Oric Pharmaceuticals IncORIC | COM | 68622P109 | 20.6 | 0.8% | 1,900,000 | Added+500,000 | |
| Bridgebio Pharma IncBBIO | COM | 10806X102 | 20.5 | 0.8% | 275,000 | Unchanged | |
| Vertex Pharmaceuticals IncVRTX | COM | 92532F100 | 19.9 | 0.8% | 40,000 | Unchanged | |
| Alumis IncALMS | COM | 022307102 | 19.7 | 0.8% | 700,000 | Reduced−100,000 | |
| Elevance Health Inc FormerlyELV | COM | 036752103 | 19.3 | 0.8% | 50,000 | Reduced−25,000 | |
| Centene Corp DelCNC | COM | 15135B101 | 19.3 | 0.8% | 300,000 | Reduced−350,000 | |
| Erasca IncERAS | COM | 29479A108 | 18.3 | 0.7% | 1,000,000 | Added+300,000 | |
| ELI Lilly & CoLLY | COM | 532457108 | 18.0 | 0.7% | 15,000 | Unchanged | |
| Arrowhead Pharmaceuticals inARWR | COM | 04280A100 | 16.3 | 0.6% | 200,000 | Reduced−100,000 | |
| Envista Holdings CorporationNVST | COM | 29415F104 | 15.8 | 0.6% | 600,000 | Added+250,000 | |
| Medtronic plc | SHS | G5960L103 | 15.6 | 0.6% | 200,000 | New+200,000 | |
| Waters CorpWAT | COM | 941848103 | 15.0 | 0.6% | 40,000 | New+40,000 | |
| Livanova plc | SHS | G5509L101 | 14.8 | 0.6% | 180,000 | Added+30,000 | |
| Novo-Nordisk a SNVO | ADR | 670100205 | 14.4 | 0.6% | 300,000 | Call | New+300,000 |
| Forte Biosciences Inc | COM NEW | 34962G208 | 14.3 | 0.6% | 675,000 | Added+525,000 | |
| Madrigal Pharmaceuticals IncMDGL | COM | 558868105 | 13.4 | 0.5% | 25,000 | Unchanged | |
| Praxis Precision Medicines IPRAX | COM NEW | 74006W207 | 13.4 | 0.5% | 40,000 | Unchanged | |
| Alto Neuroscience IncANRO | COM SHS | 02157Q109 | 13.2 | 0.5% | 500,000 | Unchanged | |
| Mineralys Therapeutics IncMLYS | COM | 603170101 | 12.1 | 0.5% | 450,000 | Reduced−300,000 | |
| Xenon Pharmaceuticals IncXENE | COM | 98420N105 | 12.1 | 0.5% | 200,000 | Unchanged | |
| Ascendis Pharma A/S | ORD SHS | K08588103 | 12.0 | 0.5% | 45,000 | New+45,000 | |
| Acadia Healthcare Company inACHC | COM | 00404A109 | 11.8 | 0.5% | 400,000 | Added+200,000 | |
| Irhythm Holdings IncIRTC | COM | 450056106 | 10.7 | 0.4% | 90,000 | New+90,000 | |
| Biohaven Ltd | COM | G1110E107 | 10.4 | 0.4% | 700,000 | Reduced−300,000 | |
| Beam Therapeutics IncBEAM | COM | 07373V105 | 10.3 | 0.4% | 300,000 | Unchanged | |
| Integra Lifesciences Holdings CIART | COM NEW | 457985208 | 9.9 | 0.4% | 550,000 | New+550,000 | |
| GE Healthcare Technologies IGEHC | COMMON STOCK | 36266G107 | 9.6 | 0.4% | 150,000 | New+150,000 | |
| Regenxbio IncRGNX | COM | 75901B107 | 9.6 | 0.4% | 800,000 | Reduced−700,000 | |
| Absci CorporationABSI | COM | 00091E109 | 9.3 | 0.4% | 800,000 | New+800,000 | |
| Bruker CorpBRKR | COM | 116794108 | 9.0 | 0.4% | 150,000 | New+150,000 | |
| Cencora IncCOR | COM | 03073E105 | 8.5 | 0.3% | 30,000 | New+30,000 | |
| Cogent Biosciences IncCOGT | COM | 19240Q201 | 7.7 | 0.3% | 200,000 | Reduced−150,000 | |
| Enliven Therapeutics IncELVN | COM | 29337E102 | 7.6 | 0.3% | 150,000 | New+150,000 | |
| Bioage Labs IncBIOA | COM | 09077V100 | 7.4 | 0.3% | 300,000 | New+300,000 | |
| Jazz Pharmaceuticals plc | SHS USD | G50871105 | 7.2 | 0.3% | 30,000 | New+30,000 | |
| Sana Biotechnology IncSANA | COM | 799566104 | 7.0 | 0.3% | 2,000,000 | Reduced−1,200,000 | |
| Inventiva SAIVA | ADS | 46124U107 | 5.7 | 0.2% | 1,520,000 | Added+1,120,000 | |
| Protara Therapeutics IncTARA | COM STK | 74365U107 | 5.7 | 0.2% | 1,500,000 | Reduced−250,000 | |
| Alkermes plc | SHS | G01767105 | 5.2 | 0.2% | 100,000 | New+100,000 | |
| LB Pharmaceuticals IncLBRX | COM SHS | 50180M108 | 4.9 | 0.2% | 150,000 | Unchanged | |
| Kardigan IncKARD | COM | 485925101 | 4.8 | 0.2% | 200,000 | New+200,000 | |
| Biontech SEBNTX | SPONSORED ADS | 09075V102 | 4.7 | 0.2% | 50,000 | New+50,000 | |
| Inspire Med Sys IncINSP | COM | 457730109 | 4.5 | 0.2% | 100,000 | New+100,000 | |
| Trevi Therapeutics IncTRVI | COM | 89532M101 | 3.7 | 0.1% | 200,000 | New+200,000 | |
| Ideaya Biosciences IncIDYA | COM | 45166A102 | 3.7 | 0.1% | 100,000 | New+100,000 | |
| Celldex Therapeutics Inc NewCLDX | COM NEW | 15117B202 | 3.7 | 0.1% | 100,000 | New+100,000 | |
| Savara IncSVRA | COM | 805111101 | 3.7 | 0.1% | 600,000 | Unchanged | |
| Relmada Therapeutics IncRLMD | COM | 75955J402 | 3.5 | 0.1% | 500,000 | Added+50,000 | |
| Mobia Med IncMOBI | COMMON STOCK | 60705V103 | 3.4 | 0.1% | 250,000 | New+250,000 | |
| Sionna Therapeutics IncSION | COM | 829401108 | 3.3 | 0.1% | 75,000 | Added+25,000 | |
| Veradermics IncMANE | COMMON STOCK | 922967104 | 3.1 | 0.1% | 25,000 | New+25,000 | |
| Inhibikase Therapeutics IncIKT | COM NEW | 45719W205 | 2.7 | 0.1% | 1,350,000 | Unchanged | |
| Rezolute IncRZLT | COM NEW | 76200L309 | 2.6 | 0.1% | 500,000 | Reduced−1,500,000 | |
| Denali Therapeutics IncDNLI | COM | 24823R105 | 2.6 | 0.1% | 100,000 | New+100,000 | |
| Tenax Therapeutics IncTENX | COM NEW | 88032L605 | 2.4 | <0.1% | 167,000 | Unchanged | |
| Olema Pharmaceuticals IncOLMA | COM | 68062P106 | 1.3 | <0.1% | 100,000 | Reduced−50,000 | |
| Aura Biosciences IncAURA | COM | 05153U107 | 1.2 | <0.1% | 170,000 | New+170,000 |
Sold out: 29 positions
Held at the end of the quarter before and not reported this quarter.
| Issuer | Class | CUSIP | Reported value$ | Weight | Shares | Put or call | Change on the quarter before |
|---|---|---|---|---|---|---|---|
| Ascendis Pharma A/S | SPONSORED ADR | 04351P101 | 0.0 | 0.0% | 0 | Sold out−115,000 | |
| Astrazeneca plc | ORD | G0593M107 | 0.0 | 0.0% | 0 | Sold out−250,000 | |
| Capricor Therapeutics IncCAPR | COM NEW | 14070B309 | 0.0 | 0.0% | 0 | Sold out−200,000 | |
| Celcuity IncCELC | COM | 15102K100 | 0.0 | 0.0% | 0 | Sold out−80,000 | |
| Cooper Cos IncCOO | COM | 216648501 | 0.0 | 0.0% | 0 | Sold out−150,000 | |
| Cytokinetics IncCYTK | COM NEW | 23282W605 | 0.0 | 0.0% | 0 | Call | Sold out−1,000,000 |
| Dexcom IncDXCM | COM | 252131107 | 0.0 | 0.0% | 0 | Sold out−175,000 | |
| Dianthus Therapeutics IncDNTH | COM | 252828108 | 0.0 | 0.0% | 0 | Sold out−150,000 | |
| Disc Medicine IncIRON | COM | 254604101 | 0.0 | 0.0% | 0 | Sold out−170,000 | |
| Elanco Animal Health IncELAN | COM | 28414H103 | 0.0 | 0.0% | 0 | Sold out−550,000 | |
| Evommune IncEVMN | COM SHS | 30054Y107 | 0.0 | 0.0% | 0 | Sold out−225,000 | |
| Fresenius Medical Care AGFMS | SPONSORED ADR | 358029106 | 0.0 | 0.0% | 0 | Sold out−775,000 | |
| Gilead Sciences IncGILD | COM | 375558103 | 0.0 | 0.0% | 0 | Sold out−100,000 | |
| Immunocore Holdings plcIMCR | ADS | 45258D105 | 0.0 | 0.0% | 0 | Sold out−100,000 | |
| Intuitive Surgical IncISRG | COM NEW | 46120E602 | 0.0 | 0.0% | 0 | Sold out−35,000 | |
| Ionis Pharmaceuticals IncIONS | COM | 462222100 | 0.0 | 0.0% | 0 | Sold out−125,000 | |
| Iqvia Holdings IncIQV | COM | 46266C105 | 0.0 | 0.0% | 0 | Sold out−35,000 | |
| Maze Therapeutics IncMAZE | COM | 578784100 | 0.0 | 0.0% | 0 | Sold out−100,000 | |
| Mineralys Therapeutics IncMLYS | COM | 603170101 | 0.0 | 0.0% | 0 | Call | Sold out−500,000 |
| Nurix Therapeutics IncNRIX | COM | 67080M103 | 0.0 | 0.0% | 0 | Sold out−700,000 | |
| Protagonist Therapeutics IncPTGX | COM | 74366E102 | 0.0 | 0.0% | 0 | Sold out−50,000 | |
| Revolution Medicines IncRVMD | COM | 76155X100 | 0.0 | 0.0% | 0 | Call | Sold out−500,000 |
| Soleno Therapeutics Inc | COM | 834203309 | 0.0 | 0.0% | 0 | Sold out−325,000 | |
| Syndax Pharmaceuticals IncSNDX | COM | 87164F105 | 0.0 | 0.0% | 0 | Sold out−350,000 | |
| Tarsus Pharmaceuticals IncTARS | COM | 87650L103 | 0.0 | 0.0% | 0 | Sold out−200,000 | |
| Thermo Fisher Scientific IncTMO | COM | 883556102 | 0.0 | 0.0% | 0 | Sold out−20,000 | |
| Unicycive Therapeutics IncUNCY | COM NEW | 90466Y202 | 0.0 | 0.0% | 0 | Sold out−225,000 | |
| Viking Therapeutics IncVKTX | COM | 92686J106 | 0.0 | 0.0% | 0 | Sold out−250,000 | |
| Zimmer Biomet Holdings IncZBH | COM | 98956P102 | 0.0 | 0.0% | 0 | Sold out−50,000 |
Source: SEC EDGAR, Form 13F-HR, accession 0001172661-26-003449 (on sec.gov). Last ingested by Listed: Oct 22, 2026, 05:26 ET. Listed shows no prices and gives no investment advice.